AIIRD | Immunomodulating agents | Vaccines |
---|---|---|
Rheumatoid arthritis | Corticosteroids | BCG |
Serum lupus erythematosus | Methotrexate | Cholera |
Antiphospholipid syndrome | Sulfasalazine | Diphtheria |
Adult Still disease | Leflunomide | Hepatitis A |
Systemic sclerosis | Hydroxychloroquine | Hepatitis B |
Sjögren syndrome | Azathioprine | Haemophilus influenzae b |
Mixed connective tissue disease | Mycophenolic acid preparations | Human papillomavirus |
Relapsing polychondritis | Ciclosporine | Influenza |
Giant cell arteritis | Tacrolimus | Japanese encephalitis |
Polymyalgia rheumatica | Cyclophosphamide | Measles* |
Takayasu arteritis | Biologicals: | Mumps* |
Polyarteritis nodosa | TNFα blocking agents | Neisseria meningitidis (A/C/Y/W135, C conjugated) |
ANCA-associated vasculitis | Infliximab | Pertussis |
Microscopic polyangiitis | Etanercept | Poliomyelitis (parenteral and oral*) |
Wegener granulomatosis | Adalimumab | Rabies |
Churg-Strauss syndrome | Rituximab | Rubella* |
Behçet disease | Tocilizumab | Streptococcus pneumoniae (polysaccharide and conjugated) |
Goodpasture disease | Abatacept | Tetanus toxoid |
Cryoglobulinaemic syndrome | Anakinra | Tick-borne encephalitis |
Polymyositis | Typhoid fever (parenteral and oral*) | |
Dermatomyositis | Varicella zoster* | |
Clinically amyopathic dermatomyositis | Yellow fever* | |
Sporadic inclusion body myositis | ||
Antisynthetase syndrome | ||
Eosinophilic myositis | ||
Eosinophilic fasciitis | ||
Spondylathropathies | ||
Periodic fever syndromes |
↵* Live attenuated vaccines.
AIIRD, autoimmune inflammatory rheumatic diseases; BCG, Bacillus Calmette-Guérin.